Update on Phase II/III clinical trial of investigational staphylococcus aureus vaccine, V710
11 April 2011 | By Merck
After a pre-specified interim analysis the DMC has recommended suspension of enrollment...
List view / Grid view
News
immatics to receive support from Pfizer for its pivotal Phase III study (IMPRINT) with IMA901
11 April 2011 | By Citigate Dewe Rogerson Ltd
immatics, announced that Pfizer are to support its pivotal Phase III trial (IMPRINT) with IMA901...
Sanofi-Aventis completes acquisition of Genzyme Corporation
8 April 2011 | By Sanofi-Aventis
Sanofi-aventis has announced that it has completed its acquisition of Genzyme Corporation...
Amgen establishes commercial operations in Brazil
8 April 2011 | By Amgen
Amgen announced today the expansion of its operations in Brazil, including the acquisition of Bergamo...
Johnson & Johnson announces settlement with U.S. Department of Justice and U.S. Securities and Exchange Commission
8 April 2011 | By Johnson & Johnson
Johnson & Johnson announced today it will pay $70,006,316 in fines...
Novartis shareholders approve merger of Alcon into Novartis
8 April 2011 | By Novartis
Novartis shareholders followed the Board of Directors' recommendation, approving the proposed merger of Alcon, Inc. into Novartis...
FDA approves orphan drug vandetanib
7 April 2011 | By AstraZeneca
AstraZeneca today announced that the FDA approved the orphan drug vandetanib for the treatment of medullary thyroid cancer...
Roche announces positive Phase II results for trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer
7 April 2011 | By Roche
Roche announced topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer...
Wyatt Technology unveils new brochure for its Möbius Mobility Instrument
7 April 2011 | By The Scott Partnership
Wyatt Technology Corporation, has published a brochure in support of its new electrophophoretic mobility instrument...
Thermo Fisher Scientific demonstrates its FT-IR instrumentation
7 April 2011 | By The Scott Partnership
Thermo Fisher Scientific Inc. highlights that its FT-IR instrumentation provides scientists with increased confidence in their results...
IDT PrimeTime Pre-designed Assays increase qPCR accuracy and efficiency
5 April 2011 | By Alto Marketing Limited
IDT, now offers PrimeTime Pre-designed qPCR Assays which are guaranteed to work for human, mouse, and rat transcriptomes...
Tecan Infinite® F200 PRO offers flexibility for drug discovery
5 April 2011 | By kdm communications limited
Euroscreen S.A., has chosen Tecan’s flexible Infinite® F200 PRO multimode plate reader for a variety of screening applications...
Molecular testing has a long way to go, says NCCN panel
5 April 2011 | By Chandler Chicco Agency
Molecular testing in cancer is "an immature industry," according to a prominent oncologist...
Thermo Fisher Scientific adds Pilgrim Software to Informatics Global Partner Alliance
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Pilgrim Software has joined the company's Informatics Global Partner Alliance. Tampa, Fla.-based Pilgrim Software, Inc. will provide integrated risk, compliance and quality management solutions to Thermo Fisher's informatics customers operating in highly regulated environments.
Thermo Fisher Scientific announces SampleManager 10.0 LIMS at Pittcon 2011
Thermo Fisher Scientific Inc., the world leader in serving science, today announced Thermo Scientific SampleManager 10.0 LIMS (laboratory information management system), a solution that delivers significant new time and cost savings for scientists and lab managers across the broadest range of process industries.
